Binkley, N., Silverman, S. L., Simonelli, C., Santiago, N., Kohles, J. D., Dasic, G., & Sunyecz, J. A. (2009). Monthly ibandronate suppresses serum CTX-I within 3 days and maintains a monthly fluctuating pattern of suppression. Osteoporosis International, 20(9), 1595. https://doi.org/10.1007/s00198-008-0827-4
Chicago Style (17th ed.) CitationBinkley, N., S. L. Silverman, C. Simonelli, N. Santiago, J. D. Kohles, G. Dasic, and J. A. Sunyecz. "Monthly Ibandronate Suppresses Serum CTX-I Within 3 Days and Maintains a Monthly Fluctuating Pattern of Suppression." Osteoporosis International 20, no. 9 (2009): 1595. https://doi.org/10.1007/s00198-008-0827-4.
MLA (9th ed.) CitationBinkley, N., et al. "Monthly Ibandronate Suppresses Serum CTX-I Within 3 Days and Maintains a Monthly Fluctuating Pattern of Suppression." Osteoporosis International, vol. 20, no. 9, 2009, p. 1595, https://doi.org/10.1007/s00198-008-0827-4.